Ribosomal protein L23a pseudogene 10 (RPL23AP10)

Ribosomal protein L23a pseudogene 10 (RPL23AP10) is classified as a pseudogene, specifically one related to the functional ribosomal protein L23a gene[1]. Pseudogenes are genetic sequences similar to known genes but are typically non-functional and do not encode active proteins. There is no direct evidence that RPL23AP10 encodes a protein or performs any known biological function, and it is not considered a therapeutic target such as a receptor, enzyme, transporter, or similar molecule. Data specific to RPL23AP10 regarding human disease roles, pharmacological modulation, or clinical biomarkers is not documented, and no interacting drugs or mechanisms of action are known[1]. The most closely related functional gene, RPL23A, encodes a component of the 60S large ribosomal subunit involved in protein synthesis; however, this function does not extend to its pseudogenes such as RPL23AP10. Therefore, RPL23AP10 should not be considered a target for therapeutic intervention. Explanation of critical points: - The gene is a **pseudogene**, meaning it does not encode a functional protein[1]. - No data suggests it acts as a drug target, receptor, transporter, enzyme, or direct biomarker. - There is no evidence of therapeutic/drug interactions, safety concerns, or defined biological function. - The entry is not suitable for target information extraction due to its non-coding, non-functional status[1]. If you meant a related functional gene such as "ribosomal protein L23a" (RPL23A) or another ribosomal protein pseudogene with established biomedical relevance, please clarify, as this entry shows no therapeutic or targeting significance.

Other names

RPL23A_28_1405RPL23AP10